73 related articles for article (PubMed ID: 8901147)
1. Improvement of glucose metabolism in patients with type II diabetes after treatment with a hemodialysate.
Jacob S; Dietze GJ; Machicao F; Kuntz G; Augustin HJ
Arzneimittelforschung; 1996 Mar; 46(3):269-72. PubMed ID: 8901147
[TBL] [Abstract][Full Text] [Related]
2. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid.
Jacob S; Henriksen EJ; Tritschler HJ; Augustin HJ; Dietze GJ
Exp Clin Endocrinol Diabetes; 1996; 104(3):284-8. PubMed ID: 8817248
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid.
Jacob S; Henriksen EJ; Schiemann AL; Simon I; Clancy DE; Tritschler HJ; Jung WI; Augustin HJ; Dietze GJ
Arzneimittelforschung; 1995 Aug; 45(8):872-4. PubMed ID: 7575750
[TBL] [Abstract][Full Text] [Related]
4. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
5. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
Vestergaard H
Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
[TBL] [Abstract][Full Text] [Related]
6. Short-term effects of metformin in type 2 diabetes.
Eriksson A; Attvall S; Bonnier M; Eriksson JW; Rosander B; Karlsson FA
Diabetes Obes Metab; 2007 May; 9(3):330-6. PubMed ID: 17391159
[TBL] [Abstract][Full Text] [Related]
7. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
Chazova I; Almazov VA; Shlyakhto E
Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
9. [Reaction of blood sugar and serum insulin to intravenous longterm treatment with Actovegin. Clinical double-blind study (author's transl)].
Heidrich H; Quednau J; Schirop T
Med Klin; 1979 Feb; 74(7):242-5. PubMed ID: 763217
[TBL] [Abstract][Full Text] [Related]
10. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients.
Mayorov AY; Naumenkova IV; Antsiferov MB; Dedov II
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S54-9. PubMed ID: 15955377
[TBL] [Abstract][Full Text] [Related]
11. Short-term effects of metformin in type 2 diabetes.
Eriksson A; Attvall S; Bonnier M; Eriksson JW; Rosander B; Karlsson FA
Diabetes Obes Metab; 2007 Jul; 9(4):483-9. PubMed ID: 17587390
[TBL] [Abstract][Full Text] [Related]
12. Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance.
Eriksson JG; Lehtovirta M; Ehrnström B; Salmela S; Groop L
J Intern Med; 2006 Jun; 259(6):553-60. PubMed ID: 16704555
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of exercise on glucose tolerance in non-insulin-dependent diabetes.
Rogers MA
Med Sci Sports Exerc; 1989 Aug; 21(4):362-8. PubMed ID: 2674587
[TBL] [Abstract][Full Text] [Related]
14. [Glucose toxicity--pros and cons. Useful adaptation and common cause of insulin resistance in diabetic patients].
Yki-Järvinen H
Nord Med; 1996 Mar; 111(3):80-3. PubMed ID: 8628644
[TBL] [Abstract][Full Text] [Related]
15. [Improved insulin action by ACE inhibition in type-2 diabetics].
Rett K; Lotz N; Wicklmayr M; Fink E; Jauch KW; Günther B; Dietze G
Dtsch Med Wochenschr; 1988 Feb; 113(7):243-9. PubMed ID: 3277829
[TBL] [Abstract][Full Text] [Related]
16. Oral hypoglycaemic agents in the treatment of immunogenic insulin resistance in NIDDM.
Ramachandran A; Snehalatha C; Mohan V; Rao CA; Viswanathan M
Diabete Metab; 1987 Apr; 13(2):140-1. PubMed ID: 3595969
[No Abstract] [Full Text] [Related]
17. [The effect of chromium supplementation on glucose tolerance, insulin response and serum lipids in maturity-onset diabetes].
Uusitupa M; Kumpulainen J; Voutilainen E; Sarlund H; Hersio K; Pyörälä K; Koivistoinen P; Lehto J
Duodecim; 1984; 100(1):29-34. PubMed ID: 6365508
[No Abstract] [Full Text] [Related]
18. [Oral actovegin therapy in cerebrovascular insufficiency. Studies on the therapeutic value of actovegin forte dragees in elderly patients with advanced cerebrovascular insufficiency].
Kopp H
Fortschr Med; 1979 Feb; 97(7):307-12. PubMed ID: 437665
[TBL] [Abstract][Full Text] [Related]
19. Actovegin improves skeletal muscle mitochondrial respiration and functional aerobic capacity in a type 1 diabetic male murine model.
Kosik B; Larsen S; Bergdahl A
Appl Physiol Nutr Metab; 2024 Feb; 49(2):265-272. PubMed ID: 37913525
[TBL] [Abstract][Full Text] [Related]
20. Rapid improvement in insulin sensitivity during glycaemic regulation in NIDDM subjects.
Ramachandran A; Snehalatha C; Mohan V; Rao CA; Kumar GV; Viswanathan M
J Assoc Physicians India; 1988 Aug; 36(8):508-10. PubMed ID: 3073154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
